NI201200176A - Derivados de 3, 4 - dihidropirrolo [ 1, 2 - a] pirazina - 2, 8 (1h) - dicarboxamida su preparación y su uso terapéutico. - Google Patents
Derivados de 3, 4 - dihidropirrolo [ 1, 2 - a] pirazina - 2, 8 (1h) - dicarboxamida su preparación y su uso terapéutico.Info
- Publication number
- NI201200176A NI201200176A NI201200176A NI201200176A NI201200176A NI 201200176 A NI201200176 A NI 201200176A NI 201200176 A NI201200176 A NI 201200176A NI 201200176 A NI201200176 A NI 201200176A NI 201200176 A NI201200176 A NI 201200176A
- Authority
- NI
- Nicaragua
- Prior art keywords
- alkyl
- cycloalkyl
- group
- therapeutic use
- hydroxy
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Anesthesiology (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Immunology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Vascular Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Compuestos que responden a la fórmula general (I) en la que R2 representa un grupo alquilo - C1-10, cicloalquilo - C3-10, cicloalquil - C3-7 - alquilo - C1-6, alquilo - C1-6 - cicloalquilo - C3-7, cicloalquil - C3-7 - cicloalquilo - C3-7, alquiltio - C1-6 - alquilo - C1-10, alcoxi - C1-6 - alquilo - C1-10, hidroxi - alquilo - C1-10, hidroxi - alquil - C1-6 - cicloalquil - C3-7 -alquilo - C1-6, hidroxi - cicloalquilo - C3-10, fluoroalquilo - C1-10, fluorocicloalquilo - C3-10; un grupo heterocíclico sustituido opcionalmente; un grupo alquilo - C1-10 sustituido con un grupo heterocíclico sustituido opcionalmente; X6 representa un grupo elegido entre el átomo de hidrógeno, de flúor, de cloro o de bromo o un grupo alquilo C1-6, cicloalquilo - C3 7, cicloalquil - C3-7 - alquilo - C1-6, fluoroalquilo - C1-6 o ciano; y R7 representa un grupo arilo tal como fenilo o naftilo, sustituidos opcionalmente con uno o varios sustituyentes en el estado de base o de sal de adición a un ácido. Uso terapéutico.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR1054372A FR2960876B1 (fr) | 2010-06-03 | 2010-06-03 | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NI201200176A true NI201200176A (es) | 2013-02-06 |
Family
ID=42697541
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NI201200176A NI201200176A (es) | 2010-06-03 | 2012-11-30 | Derivados de 3, 4 - dihidropirrolo [ 1, 2 - a] pirazina - 2, 8 (1h) - dicarboxamida su preparación y su uso terapéutico. |
Country Status (38)
| Country | Link |
|---|---|
| US (2) | US8791119B2 (es) |
| EP (1) | EP2588480B1 (es) |
| JP (1) | JP5995841B2 (es) |
| KR (1) | KR20130113928A (es) |
| CN (1) | CN103168041B (es) |
| AR (1) | AR081832A1 (es) |
| AU (1) | AU2011268651B2 (es) |
| BR (1) | BR112012030697A2 (es) |
| CA (1) | CA2801154C (es) |
| CL (1) | CL2012003360A1 (es) |
| CO (1) | CO6602113A2 (es) |
| CR (1) | CR20120595A (es) |
| CY (1) | CY1118512T1 (es) |
| DK (1) | DK2588480T3 (es) |
| DO (1) | DOP2012000296A (es) |
| EA (1) | EA201291364A1 (es) |
| EC (1) | ECSP12012322A (es) |
| ES (1) | ES2603420T3 (es) |
| FR (1) | FR2960876B1 (es) |
| GT (1) | GT201200319A (es) |
| HR (1) | HRP20161494T1 (es) |
| HU (1) | HUE030650T2 (es) |
| IL (1) | IL223364A (es) |
| LT (1) | LT2588480T (es) |
| MA (1) | MA34360B1 (es) |
| MX (1) | MX2012014084A (es) |
| NI (1) | NI201200176A (es) |
| NZ (1) | NZ603947A (es) |
| PE (1) | PE20130259A1 (es) |
| PL (1) | PL2588480T3 (es) |
| PT (1) | PT2588480T (es) |
| SG (1) | SG186143A1 (es) |
| SI (1) | SI2588480T1 (es) |
| TN (1) | TN2012000520A1 (es) |
| TW (1) | TWI487707B (es) |
| UY (1) | UY33428A (es) |
| WO (1) | WO2011161537A2 (es) |
| ZA (1) | ZA201209071B (es) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2960876B1 (fr) * | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
| TW201605859A (zh) * | 2013-11-14 | 2016-02-16 | 必治妥美雅史谷比公司 | 作為酪蛋白激酶１δ／ε抑制劑之新穎經取代之吡唑并－哌 |
| JP6307989B2 (ja) * | 2014-04-02 | 2018-04-11 | 住友化学株式会社 | 塩、酸発生剤、レジスト組成物及びレジストパターンの製造方法 |
| EP3609897A1 (en) * | 2017-04-12 | 2020-02-19 | H. Hoffnabb-La Roche Ag | A method for labeling of aldehyde containing target molecules |
| RU2745431C1 (ru) * | 2017-07-27 | 2021-03-25 | Цзянсу Хэнжуй Медицин Ко., Лтд. | Гетероарильное производное пиперазина, способ его получения и применение в медицине |
| TW202412758A (zh) * | 2022-06-29 | 2024-04-01 | 香港商英矽智能科技知識產權有限公司 | Fgfr2與fgfr3抑制劑及其用途 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU778870B2 (en) | 1999-02-01 | 2004-12-23 | University Of Virginia Patent Foundation | Compositions for treating inflammatory response |
| CA2466243A1 (en) * | 2001-09-19 | 2003-03-27 | Aventis Pharma S.A. | Indolizines as kinase protein inhibitors |
| GB0202015D0 (en) * | 2002-01-29 | 2002-03-13 | Hoffmann La Roche | Piperazine Derivatives |
| US7402672B2 (en) | 2003-12-11 | 2008-07-22 | Aventis Pharmaceuticals Inc. | Substituted 1H-pyrrolo[3,2-b, 3,2-c, and 2,3-c]pyridine-2-carboxamides and related analogs as inhibitors of casein kinase lepsilon |
| GB0328900D0 (en) | 2003-12-12 | 2004-01-14 | Glaxo Group Ltd | Novel compounds |
| WO2008147713A1 (en) * | 2007-05-24 | 2008-12-04 | The Regents Of The University Of California | Wnt signaling inhibitors, and methods for making and using them |
| WO2009044007A2 (fr) * | 2007-07-27 | 2009-04-09 | Sanofi-Aventis | Dérivés de 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-6-carboxamides et de 2,3,4,5-tetrahydropyrrolo[1,2-a][1,4]-diazépine-7-carboxamides, leur préparation et leur application en thérapeutique |
| CA2712265A1 (en) * | 2008-01-17 | 2009-07-23 | Gruenenthal Gmbh | Substituted sulfonamide derivatives |
| WO2009097515A2 (en) * | 2008-01-30 | 2009-08-06 | Wyeth | [a]-fused indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses |
| FR2960876B1 (fr) * | 2010-06-03 | 2012-07-27 | Sanofi Aventis | Derives de 3,4-dihydropyrrolo[1,2-a]pyrazine-2,8(1h)-dicarboxamide leur preparation et leur application en therapeutique. |
-
2010
- 2010-06-03 FR FR1054372A patent/FR2960876B1/fr not_active Expired - Fee Related
-
2011
- 2011-06-01 NZ NZ603947A patent/NZ603947A/en not_active IP Right Cessation
- 2011-06-01 SG SG2012088795A patent/SG186143A1/en unknown
- 2011-06-01 JP JP2013513006A patent/JP5995841B2/ja not_active Expired - Fee Related
- 2011-06-01 ES ES11781590.2T patent/ES2603420T3/es active Active
- 2011-06-01 EA EA201291364A patent/EA201291364A1/ru unknown
- 2011-06-01 MA MA35524A patent/MA34360B1/fr unknown
- 2011-06-01 SI SI201131022A patent/SI2588480T1/sl unknown
- 2011-06-01 BR BR112012030697A patent/BR112012030697A2/pt not_active IP Right Cessation
- 2011-06-01 CN CN201180038277.8A patent/CN103168041B/zh not_active Expired - Fee Related
- 2011-06-01 CA CA2801154A patent/CA2801154C/en not_active Expired - Fee Related
- 2011-06-01 HU HUE11781590A patent/HUE030650T2/en unknown
- 2011-06-01 PT PT117815902T patent/PT2588480T/pt unknown
- 2011-06-01 WO PCT/IB2011/001594 patent/WO2011161537A2/en active Application Filing
- 2011-06-01 DK DK11781590.2T patent/DK2588480T3/en active
- 2011-06-01 PL PL11781590T patent/PL2588480T3/pl unknown
- 2011-06-01 PE PE2012002257A patent/PE20130259A1/es not_active Application Discontinuation
- 2011-06-01 KR KR1020127031424A patent/KR20130113928A/ko active Search and Examination
- 2011-06-01 LT LTEP11781590.2T patent/LT2588480T/lt unknown
- 2011-06-01 MX MX2012014084A patent/MX2012014084A/es active IP Right Grant
- 2011-06-01 AU AU2011268651A patent/AU2011268651B2/en not_active Ceased
- 2011-06-01 EP EP11781590.2A patent/EP2588480B1/en active Active
- 2011-06-02 AR ARP110101901A patent/AR081832A1/es not_active Application Discontinuation
- 2011-06-03 UY UY0001033428A patent/UY33428A/es unknown
- 2011-06-03 TW TW100119696A patent/TWI487707B/zh not_active IP Right Cessation
-
2012
- 2012-10-31 TN TNP2012000520A patent/TN2012000520A1/en unknown
- 2012-11-22 DO DO2012000296A patent/DOP2012000296A/es unknown
- 2012-11-26 CR CR20120595A patent/CR20120595A/es unknown
- 2012-11-27 GT GT201200319A patent/GT201200319A/es unknown
- 2012-11-29 US US13/688,916 patent/US8791119B2/en not_active Expired - Fee Related
- 2012-11-29 IL IL223364A patent/IL223364A/en not_active IP Right Cessation
- 2012-11-30 CL CL2012003360A patent/CL2012003360A1/es unknown
- 2012-11-30 NI NI201200176A patent/NI201200176A/es unknown
- 2012-11-30 ZA ZA2012/09071A patent/ZA201209071B/en unknown
- 2012-12-03 EC ECSP12012322 patent/ECSP12012322A/es unknown
- 2012-12-03 CO CO12218640A patent/CO6602113A2/es active IP Right Grant
-
2014
- 2014-07-23 US US14/339,112 patent/US9233965B2/en not_active Expired - Fee Related
-
2016
- 2016-11-11 HR HRP20161494TT patent/HRP20161494T1/hr unknown
- 2016-11-16 CY CY20161101179T patent/CY1118512T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NI201200176A (es) | Derivados de 3, 4 - dihidropirrolo [ 1, 2 - a] pirazina - 2, 8 (1h) - dicarboxamida su preparación y su uso terapéutico. | |
| AR101820A1 (es) | Difluorometil-indanil-carboxamidas nicotínicas | |
| PE20120058A1 (es) | Derivados de imidazopirazina como inhibidores de syk | |
| PE20161405A1 (es) | Analogos de cortistatina y sintesis y usos de los mismos | |
| CO6592042A2 (es) | Derivados de n3-sustituido -n1-sulfonil-5-fluorpirimidinona | |
| ES2531274T3 (es) | Indazoles sustituidos con oxazol como inhibidores de PI3-cinasas | |
| AR098912A1 (es) | Inhibidores de syk | |
| CU20140110A7 (es) | Compuestos heterocíclicos como inhibidores de mek | |
| AR094911A1 (es) | SALES DE DERIVADOS DE 2-AMINO-1-HIDROXIETIL-8-HIDROXIQUINOLIN-2(1H)-ONA QUE TIENEN ACTIVIDAD AGONISTA DEL RECEPTOR b2 ADRENÉRGICO ASÍ COMO ACTIVIDAD ANTAGONISTA DEL RECEPTOR MUSCARÍNICO M₃ | |
| CO6491116A2 (es) | Derivados de 5-fluoropirimidinona | |
| UY32631A (es) | Derivados de ciclopenta[c]pirrol-2-carboxilatos, su preparación y su aplicación en terapéutica. | |
| MX2015003538A (es) | Derivados de 3-fenilisoxazolina con accion herbicida. | |
| UY32630A (es) | Derivados de 7-aza-espiro[3.5]nonano-7-carboxilatos, su preparación y su aplicación en terapéutica. | |
| CR20150254A (es) | Compuestos quimicos | |
| ES2601956T3 (es) | Composición para batería de litio que comprende al menos un compuesto de flúor específico como disolvente orgánico y al menos una sal de litio | |
| CO6362007A2 (es) | Derivados de azaspiranil-alquilcarbamatos de heterociclos de 5 eslabones, su preparación y su aplicación en terapeútica | |
| UY35229A (es) | Compuestos de diona cíclica herbicidas, derivados de los mismos, métodos de control de malezas y composiciones de los mismos | |
| ECSP12011652A (es) | Derivados de 5-fluoro-2-oxopirimidinona-1 (2h)-carboxamida substituida-n1 | |
| AR083301A1 (es) | Uso de composiciones de halogeno organico para reducir las emisiones de mercurio durante la combustion de carbon | |
| UY32246A (es) | Derivados de carbamatos de alquil-heterociclos, su preparación y su aplicación en terapéutica | |
| AR073008A1 (es) | Compuestos de 2- aminopirimidina como potentes inhibidores de hsp-90 | |
| ES2546833T3 (es) | Derivados de pirrolidina como antagonistas de receptores de NK-3 | |
| AR070074A1 (es) | Derivados 6- heterociclico- imidazo ( 1,2-alfa) piridina -2- carboxamidas, su preparacion y su aplicacion en terapeutica | |
| AR077395A1 (es) | Derivados de 2- 1,2 -bencisoxazol-3-il ) bencilamina | |
| ECSP12012047A (es) | Derivados de 2-aldoximino-5-fluoropirimidina |